Japan halts vaccines after 4 children die
Tokyo, March 7, 2011
Japan's health ministry has halted the use of vaccines made by Pfizer and Sanofi-Aventis to prevent meningitis and pneumonia following the deaths of four children.
The infants died shortly after receiving the vaccines and while it was unclear if there was link between the deaths and vaccines, use of Pfizer's Prevenar and Sanofi's ActHIB will be suspended while the deaths are investigated, the ministry said in a statement.
A ministry safety panel is scheduled to discuss findings in the investigations on Tuesday.
In February last year health authorities in the Netherlands said no relation was found between Prevenar and the deaths of three infants who had received the vaccine.
Three of the children that died in Japan were administered Prevenar together with ActHIB. In addition, three of the children also received a mixed vaccine against diphtheria, whooping cough and tetanus on the same day they received the other vaccines.
Three of the four children died a day after being immunised. The deaths happened between March 2 and March 4.
Representatives for Pfizer and Sanofi in Tokyo said the companies were cooperating with the investigation.
A spokesman for Sanofi said that the company has shipped more than 3 million doses of ActHIB in Japan since 2008 while a spokesman for Pfizer said the firm has distributed more than 2 million doses of Prevenar in Japan since last year. - Reuters
More Health & Environment Stories
- SARS virus claims one more victim in Saudi
- New support group comes to overeaters' rescue
- RAK Hospital launches urinary clinic for women
- NBAD backs Emiratis on Antarctica trip
- Cut sugar intake drastically urges WHO
- Al khaliji to fund Qatar recycling plant
- Qatar researcher in 360km breast cancer run
- New facilitator to open in DHCC
- Many countries lack capacity to prevent hearing loss
- QUIT NOW: Passive smoking hurts kids' arteries
- San Francisco to ban plastic water bottles
- GSK wins home toothpaste award for Sensodyne
- E-integration vital to GCC healthcare industry
- Fakih IVF unveils two new genetic tests
- 2 die from H1N1 in Oman
- Al Noor Hospitals targets domestic growth
- Medical panel on the way in Bahrain
- 40pc of UAE adults ‘have hypertension’
- Saudi diabetics urged to stay away from camels
- GCC readies plan to fight heart diseases
- Bahrain opens sickle cell hospital
- Hazardous waste focus for Oman summit
- Infectious viruses to be tracked by satellite in UAE
- Mafraq Hospital names new surgery chief
- Saudi health ministry seals BMJ partnership
- Need for medical simulation training highlighted
- UAE-France discuss healthcare collaboration
- Seha focus on patient centred services
- Saudi-Tokyo firms in wastewater technology JV
- Leading experts at Dubai diabetes conference